Annett Mueller

Cetuximab with irinotecan, folinic acid and 5-fluorouracil as first-line treatment in advanced gastroesophageal cancer: a prospective multi-center biomarker-oriented phase II study

Markus Moehler, Annett Mueller, Tanja Trarbach et al. · Annals of Oncology · 2010 · 126 citations · Full text

Medicine, Oncology, Pharmacology +16

Interferon-γ signaling in human iPSC–derived neurons recapitulates neurodevelopmental disorder phenotypes

Katherine Warre‐Cornish, Leo Perfect, Roland Nagy et al. · Science Advances · 2020 · 101 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

High miR-21 expression from FFPE tissues is associated with poor survival and response to adjuvant chemotherapy in colon cancer

Naohide Oue, Katsuhiro Anami, Aaron J. Schetter et al. · International Journal of Cancer · 2013 · 91 citations

Medicine, Oncology, Pathology +17

An open-label, multicentre biomarker-oriented AIO phase II trial of sunitinib for patients with chemo-refractory advanced gastric cancer

Markus Moehler, Annett Mueller, J.T. Hartmann et al. · European Journal of Cancer · 2011 · 88 citations

Medicine, Oncology, Pharmacology +12

Selective PI3K inhibition by BKM120 and BEZ235 alone or in combination with chemotherapy in wild-type and mutated human gastrointestinal cancer cell lines

Annett Mueller, Erika Bachmann, Monika Linnig et al. · Cancer Chemotherapy and Pharmacology · 2012 · 76 citations

Medicine, Oncology, Pharmacology +10